DrugCard
Drug safety teams monitor local medical journals often missed by global databases.
Key Takeaways
- What it is
- Drug safety teams monitor local medical journals often missed by global databases.
- Pricing
- Freemium
- Best for
- Global and local literature monitoring
- AI Agent for Literature Monitoring
- AI article analysis
- Rating
- 4.1/5
What is DrugCard?
DrugCard monitors medical literature for pharmaceutical companies, contract research organizations, and pharmacovigilance specialists who need to find drug safety information across countries. Its AI helps screen articles, summarize findings, and organize safety-related work. The aim is to reduce time spent sorting through publications while keeping decisions reviewable.
DrugCard’s standout strength is its reach into local medical journals that global databases may miss. The company says it monitors more than 2,300 local journals across 151 countries and supports more than 100 languages. That makes it especially relevant when a drug safety team needs visibility beyond English-language or widely indexed research.
Drug safety teams at marketing authorization holders, contract research organizations, and independent pharmacovigilance providers are the clearest fit. AI-generated assessments and case details still require specialist review, so DrugCard does not remove expert responsibility. It is built for regulated literature-monitoring work, not general-purpose research or everyday writing.
Who is Using DrugCard?
Pharmacovigilance Specialists
Article relevance indicators, summaries, and structured notes help specialists prioritize publications and document assessments.
Pharmacovigilance Project Managers
Project-level monitoring and audit records help managers follow screening work across products and markets.
Qualified Persons for Pharmacovigilance
Traceable screening records can support oversight of literature monitoring and safety processes.
Regulatory Affairs Specialists
The Regulatory Intelligence module helps track regulatory updates and review AI summaries of source documents.
Uncommon Use Cases
Preparing literature search evidence for aggregate safety reports; tracking regulatory updates for impact assessment
Key Features
Rating Breakdown
Pricing Plans
Free Tier
Free
- Experience DrugCard with a trial period customized upon request
Which DrugCard plan should you pick?
Start with the free two-week trial to test your monitoring workflow, then contact DrugCard to discuss a suitable paid setup.
DrugCard Use Cases
Screening local medical literature
Local-language journal monitoring brings safety-relevant publications into the same review process as global sources.
Outcome: Broader visibility into publications that may be missed by global databases.
Prioritizing article reviews
AI relevance indicators and summaries help specialists decide which publications need closer attention.
Outcome: Less time spent reading articles that are unlikely to be relevant.
Preparing safety case drafts
Structured AI extraction can carry patient, product, and reaction details into a draft case for specialist review.
Outcome: A partially completed Individual Case Safety Report draft.
Tracking regulatory updates
A searchable newsfeed and AI summaries help teams review updates from monitored regulatory sources.
Outcome: Regulatory updates collected for review and impact assessment.
Supporting aggregate reports
Documented literature searches and relevant references can support PSUR, PBRER, and DSUR preparation.
Outcome: Exportable search results and references with an audit trail.
Workflow Ideas with DrugCard
Review a new safety article
- 1Monitor configured global and local literature sources.
- 2Sort new articles using AI relevance indicators and summaries.
- 3Review the source and confirm the article’s category.
Prepare a literature-based case
- 1Open an article flagged for safety review.
- 2Check the extracted patient, product, and reaction details against the source.
- 3Create and complete the safety case draft.
Track a regulatory update
- 1Monitor selected regulatory authorities and topics.
- 2Review an update with its AI summary and source document.
- 3Save it with notes for an impact assessment.
How DrugCard fits into your stack
Literature monitoring
DrugCard searches global sources such as PubMed and Embase, as well as configured local journals. Results are collected for review in the platform.
Article review
AI indicators, summaries, and structured data support screening inside the article review workflow. Specialists remain responsible for checking and confirming the results.
Safety case processing
Literature analysis can feed a draft Individual Case Safety Report in DrugCard’s Adverse Reactions database.
Regulatory intelligence
The Regulatory Intelligence module provides searchable updates and an API for sending information to a company’s compliance systems.
Reporting and audit records
Documented searches, exports, and audit trails support aggregate reporting and traceability.
Pros
- +Local journal coverage: Monitors regional and non-indexed medical publications that global databases may not include.
- +Language reach: Supports literature screening across more than 100 languages.
- +Human review: AI outputs are presented for specialist review rather than silently becoming official records.
- +Connected case workflow: Article analysis can help prefill a safety case draft in DrugCard’s database.
Cons
- −Specialized scope: The platform is aimed at pharmacovigilance literature and drug safety work, not general research.
- −Pricing is not listed: You need to contact DrugCard to discuss platform pricing.
- −Setup takes planning: Adding journals for a new country typically takes about two to three weeks.
Limitations & when to consider alternatives
Known limitations
- New journal coverage takes time. DrugCard says adding a new set of journals for a country typically takes about two to three weeks, depending on the country and number of journals.
- AI results need specialist review. DrugCard describes AI assessments and extracted information as decision support that specialists should check and confirm.
- No public plan prices. The site directs prospective customers to contact the company about tariff plans and pricing.
Look elsewhere when
- You need a general-purpose AI tool for work outside pharmacovigilance.
- Your team needs a self-service subscription with publicly listed prices.
How to Use DrugCard
- 1
Request a demonstration or trial
Contact DrugCard to discuss the platform, a free two-week trial, and the monitoring needs of your team.
- 2
Set up users and access
Define user roles and responsibilities so each person has an account with traceable activity.
- 3
Configure monitoring projects
Set up the products, countries, sources, and search needs for each project.
- 4
Choose an AI Agent level
For supported projects, select the level of screening and categorization automation that fits your review process.
- 5
Review and confirm AI outputs
Check article assessments, notes, and extracted case details against the source before saving or acting on them.
- 6
Use the records for reporting
Export documented search results and relevant references for aggregate reports or audits.
Who is DrugCard For?
Contract Research Organizations
CROs can manage literature-monitoring work across client projects and markets with documented screening workflows.
Marketing Authorization Holders
Pharmaceutical companies can monitor local and global literature for their products and keep screening records together.
Freelance Pharmacovigilance Providers
Independent specialists can reduce manual article screening time and focus on higher-value safety work.
Frequently Asked Questions
Is there a free trial?
DrugCard’s site offers a free two-week trial. Contact the company to discuss access.
How much does DrugCard cost?
The company does not list platform prices publicly. Contact DrugCard for pricing based on your project.
Can DrugCard monitor local journals in other languages?
Yes. DrugCard says it supports more than 100 languages and monitors local medical journals across many countries.
Does DrugCard create safety cases automatically?
AI can extract case details and help create a draft, but specialists are expected to review and complete the case.
Can DrugCard connect with other systems?
The Regulatory Intelligence module offers API access to send updates to a company’s compliance systems.
Community reviews
Be the first to share your experience.
Sign in to leave a review for DrugCard.
DrugCard Alternatives
Looking for alternatives to DrugCard? Here are similar tools in the same category:
